These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8596911)

  • 1. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I).
    Multhaup G; Schlicksupp A; Hesse L; Beher D; Ruppert T; Masters CL; Beyreuther K
    Science; 1996 Mar; 271(5254):1406-9. PubMed ID: 8596911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide.
    Multhaup G; Ruppert T; Schlicksupp A; Hesse L; Bill E; Pipkorn R; Masters CL; Beyreuther K
    Biochemistry; 1998 May; 37(20):7224-30. PubMed ID: 9585534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein, copper and Alzheimer's disease.
    Multhaup G
    Biomed Pharmacother; 1997; 51(3):105-11. PubMed ID: 9181045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.
    White AR; Multhaup G; Galatis D; McKinstry WJ; Parker MW; Pipkorn R; Beyreuther K; Masters CL; Cappai R
    J Neurosci; 2002 Jan; 22(2):365-76. PubMed ID: 11784781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical.
    Dikalov SI; Vitek MP; Mason RP
    Free Radic Biol Med; 2004 Feb; 36(3):340-7. PubMed ID: 15036353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.
    Huang X; Atwood CS; Hartshorn MA; Multhaup G; Goldstein LE; Scarpa RC; Cuajungco MP; Gray DN; Lim J; Moir RD; Tanzi RE; Bush AI
    Biochemistry; 1999 Jun; 38(24):7609-16. PubMed ID: 10386999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of copper binding to amyloid precursor protein domain 2 and its Caenorhabditis elegans ortholog. Implications for biological function.
    Leong SL; Young TR; Barnham KJ; Wedd AG; Hinds MG; Xiao Z; Cappai R
    Metallomics; 2014 Jan; 6(1):105-16. PubMed ID: 24276282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper reduction by copper binding proteins and its relation to neurodegenerative diseases.
    Opazo C; Barría MI; Ruiz FH; Inestrosa NC
    Biometals; 2003 Mar; 16(1):91-8. PubMed ID: 12572668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein.
    Ruiz FH; González M; Bodini M; Opazo C; Inestrosa NC
    J Neurochem; 1999 Sep; 73(3):1288-92. PubMed ID: 10461923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-beta-peptide reduces copper(II) to copper(I) independent of its aggregation state.
    Opazo C; Ruiz FH; Inestrosa NC
    Biol Res; 2000; 33(2):125-31. PubMed ID: 15693279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis.
    Barnham KJ; McKinstry WJ; Multhaup G; Galatis D; Morton CJ; Curtain CC; Williamson NA; White AR; Hinds MG; Norton RS; Beyreuther K; Masters CL; Parker MW; Cappai R
    J Biol Chem; 2003 May; 278(19):17401-7. PubMed ID: 12611883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species and Alzheimer's disease.
    Multhaup G; Ruppert T; Schlicksupp A; Hesse L; Beher D; Masters CL; Beyreuther K
    Biochem Pharmacol; 1997 Sep; 54(5):533-9. PubMed ID: 9337068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
    La Penna G; Hureau C; Andreussi O; Faller P
    J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper catalyzed oxidation of Alzheimer Abeta.
    Atwood CS; Huang X; Khatri A; Scarpa RC; Kim YS; Moir RD; Tanzi RE; Roher AE; Bush AI
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):777-83. PubMed ID: 10875439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mechanisms of APP-mediated oxidative stress in Alzheimer's disease.
    Multhaup G; Scheuermann S; Schlicksupp A; Simons A; Strauss M; Kemmling A; Oehler C; Cappai R; Pipkorn R; Bayer TA
    Free Radic Biol Med; 2002 Jul; 33(1):45-51. PubMed ID: 12086681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
    Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
    J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper binding to the Alzheimer's disease amyloid precursor protein.
    Kong GK; Miles LA; Crespi GA; Morton CJ; Ng HL; Barnham KJ; McKinstry WJ; Cappai R; Parker MW
    Eur Biophys J; 2008 Mar; 37(3):269-79. PubMed ID: 18030462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta A4 amyloid precursor protein binding to copper.
    Hesse L; Beher D; Masters CL; Multhaup G
    FEBS Lett; 1994 Jul; 349(1):109-16. PubMed ID: 7913895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper brain homeostasis: role of amyloid precursor protein and prion protein.
    Inestrosa NC; Cerpa W; Varela-Nallar L
    IUBMB Life; 2005 Sep; 57(9):645-50. PubMed ID: 16203684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Cu2+/ascorbate-dependent oxidation of alzheimer's disease beta-amyloid peptides.
    Schöneich C
    Ann N Y Acad Sci; 2004 Mar; 1012():164-70. PubMed ID: 15105263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.